glp-1 medications tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy Q&A: How Specific GLP-1s Impact

This dual-action makes Mounjaro slightly more effective than Ozempic (Wegovy)

Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide

It arrives as either a liquid solution in a multi-use vial or as lyophilized powder that you reconstitute yourself with bacteriostatic water

You may find yourself forgetting to eat or feeling satisfied after very small portions

For people with more subcutaneous fat, the layer may be 15-20mm or deeper, making it nearly impossible to accidentally inject into muscle even at a 90-degree angle